STAND. COM. REP. NO.  984

 

Honolulu, Hawaii

                , 2015

 

RE:   S.B. No. 301

      S.D. 2

      H.D. 1

 

 

 

 

Honorable Joseph M. Souki

Speaker, House of Representatives

Twenty-Eighth State Legislature

Regular Session of 2015

State of Hawaii

 

Sir:

 

     Your Committee on Health, to which was referred S.B. No. 301, S.D. 2, entitled:

 

"A BILL FOR AN ACT RELATING TO HEALTH,"

 

begs leave to report as follows:

 

     The purpose of this measure is to help patients that are in need of drug coverage make informed decisions about their health care coverage by requiring entities that offer or renew health plans to make a complete and updated formulary publicly available.   

 

     The Hawaii Medical Association, Arthritis Foundation, and Pharmaceutical Research and Manufacturers of America supported this measure.  Kaiser Permanente and American Cancer Society Cancer Action Network supported this measure with amendments.  Hawaii Association of Health Plans opposed this measure.  The Department of Commerce and Consumer Affairs and Hawaii Medical Service Association commented on this measure.

 

     Your Committee has amended this measure by:

 

     (1)  Replacing the prescriptive provisions relating to the contents required of each formulary with a general requirement that the insurer provide a system that allows for people to determine whether certain drugs are covered, with cost-sharing information, under the plan's medical benefits;

(2)  Specifying that the formulary requirements in this measure shall not apply to limited benefit health insurance, Medicare, Medicaid, or any other federally financed plan;

 

(3)  Removing the requirement of attestation to the Insurance Commissioner;

 

(4)  Removing the provisions that allow for the Insurance Commissioner to create a standard formulary template;

 

(5)  Requiring the Insurance Commissioner to convene a Formulary Accessibility Working Group to make recommendations for a standard formulary template and report to the Legislature;

 

(6)  Changing the effective date to July 1, 2112, to encourage further discussion; and

 

(7)  Making technical, nonsubstantive amendments for clarity, consistency, and style.

 

     As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 301, S.D. 2, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 301, S.D. 2, H.D. 1, and be referred to the Committee on Consumer Protection & Commerce.

 

Respectfully submitted on behalf of the members of the Committee on Health,

 

 

 

 

____________________________

DELLA AU BELATTI, Chair